Supernus Sues Actavis, Watson Over Oxtellar XR Patents

By Kelly Knaub ( August 8, 2013, 5:35 PM EDT) -- Supernus Pharmaceuticals Inc. hit Actavis Inc. and Watson Laboratories Inc. with a lawsuit in New Jersey federal court on Wednesday alleging the drugmakers are infringing two patents covering Oxtellar XR by seeking approval to sell a generic version of the anti-epileptic drug before the patents expire. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Law360's annual list of regional powerhouses reflects not only the work of exemplary firms, but also emerging legal trends in each state, from matters involving Colorado's growing life sciences industry, to an uptick in bankruptcies in Delaware, to the continued flurry of intellectual property litigation in California.